Clinical Trial Update: Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for an inactivated bivalent enterovirus vaccine (Vero cell) from Sinovac to prevent hand, foot and mouth disease and herpangin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease
• Herpangina

Drugs mentioned

• Inactivated Bivalent Enterovirus Vaccine (Vero Cell) (Inactivated bivalent enterovirus vaccine (Vero cell))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease, Herpangina | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING